PXD023422 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Fluvastatin mitigates SARS-CoV-2 infection in human lung cells |
Description | Clinical data of patients suffering from COVID-19 have indicated that statin therapy, used to treat hypercholesterolemia, is associated with a better clinical outcome. We therefore investigated the effect of statins on SARS-CoV-2 infection in human lung cells and found that fluvastatin inhibited coronavirus infection, while other tested statins did not. Fluvastatin inhibited high and low pathogenic coronaviruses in vitro and ex vivo in a dose-dependent manner. Proteomic analyses of infected versus uninfected lung epithelial cells treated with fluvastatin, simvastatin, or rosuvastatin revealed that all tested statins modulated the cholesterol synthesis pathways without compromising the innate antiviral immune response. Strikingly, fluvastatin treatment uniquely affected the proteome of SARS CoV 2 infected cells, specifically downregulating proteins that modulate protein translation and viral replication. These results suggest that statin therapy poses no additional risk to individuals exposed to SARS-CoV-2 and that fluvastatin may have a moderate beneficial effect on SARS CoV-2 infection by modulating protein translation. |
HostingRepository | PRIDE |
AnnounceDate | 2021-12-07 |
AnnouncementXML | Submission_2021-12-07_07:28:00.315.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Lothar Jaensch |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | methylthiolated residue; monohydroxylated residue |
Instrument | timsTOF Pro |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2021-01-06 00:02:50 | ID requested | |
⏵ 1 | 2021-12-07 07:28:00 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
ProteomeXchange project tag: Sars-cov-2, Covid-19 |
submitter keyword: SARS-CoV-2, COVID-19, virus, cholesterol, hypercholesteremia, statin, risk factor, proteomics, air-liquid-interface culture, cholesterol, fluvastatin |
Contact List
Lothar Jaensch |
contact affiliation | Helmholtz Centre for Infection Reasearch, Structure and Function of proteins Division, Cellular Proteomics Group, Germany |
contact email | Lothar.jaensch@helmholtz-hzi.de |
lab head | |
Lothar Jaensch |
contact affiliation | HZI |
contact email | Lothar.Jaensch@Helmholtz-HZI.de |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/12/PXD023422 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD023422
- Label: PRIDE project
- Name: Fluvastatin mitigates SARS-CoV-2 infection in human lung cells